JSM2026
Back to all people

Hana Lee

Food and Drug Administration
1 appearance in the program

Sessions & presentations

Methods and Novel Endpoints (Patient-Reported Outcomes & Digital Health Data) in Biomedical Studies
Presentation: A CV-TMLE Global Test Approach to Multiple-Component Endpoints in Rare Disease Clinical Trials
Contributed Papers · Wed, Aug 5 , 8:30 AM
Co-Author